Selank in Puig — Anxiolytic Peptide Research Guide
Selank peptide guide for Puig. Covers anxiolytic mechanisms, purity standards, COA verification, nasal administration, and how to source quality Selank for research.
For anyone in Puig searching for Selank, the key fact to understand is that this compound is available only through an online research supply market. The key implication for Puig researchers: sourcing Selank comes down completely to vendor quality evaluation, not geography — and the quality verification approach is the same regardless of where you are. A legitimate Selank supplier's COA needs to show HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all traceable to your specific batch. This guide guides Puig researchers through that evaluation process and explains the signals that distinguish quality Selank suppliers.
How Selank Works — Mechanisms & Research
The cognitive peptide research area overlaps significantly with stress biology, given that many neuropeptides have dual roles in both cognitive and stress response pathways. Selank's activity on the GABAergic system produces anxiolytic effects alongside nootropic effects, and this co-activity is relevant to research design — cognitive outcome measures in high-anxiety model animals may reflect anxiolysis as much as direct cognitive enhancement from Selank. Separating these effects requires protocol designs that include stress-reduced control conditions. For Puig researchers in cognitive neuroscience, this mechanistic complexity is an opportunity for nuanced research design rather than a limitation.
How to Source Selank — Vendor Guide
The first step for any Puig researcher sourcing Selank is finding vendors with verified community track records — search results alone are too heavily influenced by marketing spend. When reviewing a Selank COA, verify: the batch number traces to your order, HPLC purity is ≥98%, mass spec identifies the correct molecular weight, and endotoxin levels are at acceptable levels for the intended application. Warning signs in Selank vendor evaluation: prices significantly below market average, vague sourcing information, no community presence, and COAs that lack endotoxin data. Keep lyophilised Selank at −20°C until ready to use; reconstitute only the quantity required for your immediate research and return unused portion to the freezer.
Order Selank — ships to Puig
COA-verified · International tracking · Research grade
Selank operates outside approved pharmaceutical regulation — researchers should understand that the risk characterisation for this compound is based on research literature rather than clinical trials. Lyophilised Selank should be frozen at −20°C as soon as it arrives; do not freeze and thaw reconstituted Selank multiple times by preparing small aliquots before storage. Verify the endotoxin level in your Selank batch COA before any protocol involving administration — look for results stated as EU/mg and confirm they fall within appropriate thresholds. Researchers using Selank alongside other research compounds should examine published studies for potential interaction data before running stacked compound experiments.
Frequently Asked Questions
What is the administration route for Selank research?
Like Semax, Selank is primarily studied via intranasal administration for CNS applications, utilizing olfactory nerve transport to bypass the blood-brain barrier. The solution concentration used in research is typically 0.15% (1.5mg/mL). Subcutaneous administration has also been studied in animal models.
What is Selank?
Selank is a synthetic analogue of tuftsin (a tetrapeptide fragment of immunoglobulin G) with three additional amino acids for stability. It has been studied for anxiolytic effects, cognitive enhancement, and GABAergic system modulation. Like Semax, it was developed by the Institute of Molecular Genetics in Russia and has a clinical history in Russian medicine.
Is Selank similar to Semax?
Semax and Selank are both synthetic neuropeptides developed by the same Russian institution with overlapping clinical applications. They have distinct mechanisms: Semax primarily upregulates BDNF and acts on ACTH receptor systems; Selank primarily modulates GABAergic transmission and enkephalin activity. They are sometimes studied in combination.
How does Selank produce anxiolytic effects?
Selank's anxiolytic mechanism is thought to involve modulation of GABAergic transmission (similar but distinct to benzodiazepines), inhibition of enkephalinase (extending the activity of endogenous enkephalins), and BDNF expression modulation. The multi-mechanism profile distinguishes it from single-target anxiolytics.
